Press Release for the Second Quarter and Half Year Ended 30th September, 2025 Results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanjivani Paranteral Ltd reported a weak Q2 FY26 with revenue from operations falling 14.5% year-on-year to Rs. 155.0 million and profit after tax (PAT) declining 28.6% YoY to Rs. 16.4 million. EBITDA margin came in at 15.5% versus 17.9% in the same quarter last year. The oral segment was the main drag, dropping 35.4% YoY to Rs. 49.9 million due to shipment-related challenges, while injectables grew modestly by 2.4% to Rs. 92.9 million. Exports continue to dominate, contributing 81.6% of Q2 revenue, primarily from CIS, Middle East & Africa, and Latin America. For the half year (H1 FY26), revenue declined 3.4% YoY to Rs. 333.9 million and PAT fell 16% to Rs. 33.7 million.
The double-digit decline in both revenue and profit is a negative signal for shareholders, driven mainly by weakness in the oral segment and broader global trade uncertainties. However, steady growth in the injectables segment and a strong export-led revenue mix offer some cushion, and management expects improvement in coming quarters.